Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M Warrington

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Cancer Cell|June 27, 2025
Disarming myeloid resistance in CAR T therapyJohn M Warrington, Nathan Singh
Molecular Therapy. Oncology|March 18, 2026
Dynamic regulation of BACH2 enhances CAR T cell functionTien-Ching Chang, John M Warrington, Nathan Singh
Best Practice & Research. Clinical Haematology|October 9, 2021
Advances in CAR designAmanda Heard, Jufang Chang, John M Warrington, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
A SARS-CoV-2 Vaccination Strategy Focused on Population-Scale ImmunityMark Yarmarkovich, John M Warrington, Alvin Farrel, et al.
Cell Reports. Medicine|August 25, 2020
Identification of SARS-CoV-2 Vaccine Epitopes Predicted to Induce Long-Term Population-Scale ImmunityMark Yarmarkovich, John M Warrington, Alvin Farrel, et al.
SSRN|July 28, 2020
A SARS-CoV-2 Vaccination Strategy Focused on Population-Scale ImmunityMark Yarmarkovich, John M Warrington, Alvin Farrel, et al.
Cancer Immunology Research|July 17, 2024
Regulatory Considerations for Genome-Edited T-cell TherapiesJulie K Jadlowsky, Ju-Fang Chang, David H Spencer, et al.
Cancer Discovery|July 9, 2024
Rational Protein Engineering to Enhance MHC-Independent T-cell ReceptorsJu-Fang Chang, Jack H Landmann, Tien-Ching Chang, et al.
Nature Communications|June 11, 2022
Antigen glycosylation regulates efficacy of CAR T cells targeting CD19Amanda Heard, Jack H Landmann, Ava R Hansen, et al.
Nature Immunology|January 16, 2026
BACH2 regulates T cell lineage state to enhance CAR T cell functionTien-Ching Chang, Amanda Heard, John Lattin, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Cancer Cell|June 27, 2025
Disarming myeloid resistance in CAR T therapyJohn M Warrington, Nathan Singh
Molecular Therapy. Oncology|March 18, 2026
Dynamic regulation of BACH2 enhances CAR T cell functionTien-Ching Chang, John M Warrington, Nathan Singh
Best Practice & Research. Clinical Haematology|October 9, 2021
Advances in CAR designAmanda Heard, Jufang Chang, John M Warrington, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
A SARS-CoV-2 Vaccination Strategy Focused on Population-Scale ImmunityMark Yarmarkovich, John M Warrington, Alvin Farrel, et al.
Cell Reports. Medicine|August 25, 2020
Identification of SARS-CoV-2 Vaccine Epitopes Predicted to Induce Long-Term Population-Scale ImmunityMark Yarmarkovich, John M Warrington, Alvin Farrel, et al.
SSRN|July 28, 2020
A SARS-CoV-2 Vaccination Strategy Focused on Population-Scale ImmunityMark Yarmarkovich, John M Warrington, Alvin Farrel, et al.
Cancer Immunology Research|July 17, 2024
Regulatory Considerations for Genome-Edited T-cell TherapiesJulie K Jadlowsky, Ju-Fang Chang, David H Spencer, et al.
Cancer Discovery|July 9, 2024
Rational Protein Engineering to Enhance MHC-Independent T-cell ReceptorsJu-Fang Chang, Jack H Landmann, Tien-Ching Chang, et al.
Nature Communications|June 11, 2022
Antigen glycosylation regulates efficacy of CAR T cells targeting CD19Amanda Heard, Jack H Landmann, Ava R Hansen, et al.
Nature Immunology|January 16, 2026
BACH2 regulates T cell lineage state to enhance CAR T cell functionTien-Ching Chang, Amanda Heard, John Lattin, et al.
Pageof 2